235 Followers on Owler

CSL

is an Australia-based biotechnology company that develops and commercializes novel therapeutics and vaccines for the treatment of various diseases... Read more
OverviewCompetitorsAcquisitionsFundingInvestmentsNews & Insights

CSL

is an Australia-based biotechnology company that develops and commercializes novel therapeutics and vaccines for the treatment of various diseases... Read more
CSL Interim-CEO: Gordon Naylor

Interim-CEO

Gordon Naylor

CEO Approval Rating

- -/100

1916

PublicOTCMKTSCSLLY

Pharmaceuticals & Biotechnology
Biotechnology
2834 NAICS listing

Annual Revenue
$62.2B
Employees
29,000
Funding
$750M
Acquisitions
7
Investments
1

News

Leadership Change
Feb 10, 2026
Australian Financial Review
Gordon Naylor is now Interim-CEO at CSL
investment
Sep 15, 2025
https://www.investing.com/news/stock-market-news/australias-csl-to-invest-up-to-505-mln-in-dutch-biotech-varmx-4239665
CSL Limited has invested $117M in VarmX B.V.

CSL Competitors

1Grifols
2Takeda Pharmaceutical
3Sonic Healthcare
4Baxter
5Octapharma
6Novavax
7DaVita
8Roche
9Fresenius
10Teleflex
Unlock 32 + competitors

Trending Companies